Sarah Comensoli
Exercise Physiologist & Manager of Allied Health services
Dr Herman Lau
Rheumatologist
Robyn Yin
Head Exercise Physiologist
Belinda Price
Physiotherapist
Blanche Leung
Physiotherapist
Heidi Kim
Physiotherapist
Brought to you by
Saturday 24 October
1130 – 1245
CH2: Morning symposium 1
“Beyond remission” based on patients’ subjective experiences for improved RA control
Chairpersons:
Professor Masayoshi Harigai
Professor and Chairperson of Department of rheumatology/Tokyo Women’s Medical University
Speakers:
Associate Professor Yuko Kaneko
Associate Professor, Division of Rheumatology and Department of Internal Medicine/Keio University School of Medicine
CH3: Morning symposium 2
Solving the patient puzzle: A pragmatic approach to SpA management
Speakers:
Dr Mitsumasa Kishimoto
Associate Professor, Department of Nephrology and Rheumatology/Kyorin University School of Medicine
Dr Philip Robinson
Associate Professor/Brisbane Rheumatology
CH4: Morning symposium 3
New Treatment Paradigm in RA: Focusing on A Novel JAK inhibitor
Chairpersons/Speakers:
Professor Tatsuya Atsumi
Professor of Medicine in the Faculty of Medicine/Hokkaido University
Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health
Professor Tsutomu Takeuchi
Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine
Morning symposium 4
Brought to you by
Brought to you by
Brought to you by
1315 – 1445
CH1: Lunch symposium 1
Prospects for JAK inhibitors in the treatment of rheumatoid arthritis
Speakers:
Dr Kei Ikeda
Senior Lecturer, Department of Allergy and Clinical Immunology/Chiba University Hospital
Dr Akio Morinobu
Department of Rheumatology, Kyoto University Graduate School of Medicine
Brought to you by
CH2: Lunch symposium 2
Basic and Clinical of Rheumatology
Chairpersons:
Professor Masataka Kuwana
Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School
Speakers:
Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health
Brought to you by
1740 – 1840
CH1: Evening symposium 1
Management of RA in 2020: is remission achievable and where do JAKs fit?
Speakers:
Professor Gerd-Rüdiger Burmester
Medicine Director of the department of Rheumatology
Associate Professor Peter Nash
Department of Medicine/University of Queensland, Brisbane, AUSTRALIA
CH2: Evening symposium 2
Treat-to-target in SLE: addressing short- and long-term treatment goals
Chariperson:
Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health
Speakers:
Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health
Professor Ian Bruce
National Institute of Health Research (NIHR) Senior Investigator and Professor of Rheumatology/University of Manchester
Professor Nancy Agmon-Levin
Consultant/Tel Aviv and Chaim Sheba Medical Center
CH3: Evening symposium 3
ILD in Focus: Time to prioritize the lung in CTDs
Chairperson:
Professor Masataka Kuwana
Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School
Speakers:
Professor Masataka Kuwana
Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School
Professor Yannick Allanore
Professor of Rheumatology/University of Paris
Professor Marco Matucci-Cerinic
Professor of Rheumatology and Medicine at the Department of Experimental and Clinical Medicine/Careggi University Hospital of Florence
CH4: Evening symposium 4
Perspectives around the accumulated evidence for IL-6 in autoimmune disease
Chairpersons/Speakers:
Dr Kunihiro Yamaoka
Division of Rheumatology, Kitasato University Hospital, Japan
Dr Shinsuke Yasuda
Tokyo Medical and Dental University, Department of Rheumatology, Japan
Brought to you by
Brought to you by
Brought to you by
Brought to you by
Sunday 25 October
1130 – 1245
CH2: Morning symposium 5
Treatment of Rheumatoid Arthritis: Past and Future
Speakers:
Masaru Kato
Department of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine, Hokkaido University
CH3: Morning symposium 6
To continue, taper or discontinue biologics – Implications on RA treatment outcomes
Chairpersons:
Professor Yoshiya Tanaka
University of Occupational and Environmental Health, Kitakyushu, JAPAN
Speakers:
Associate Professor Peter Nash
Department of Medicine / University of Queensland, Brisbane, AUSTRALIA
Associate Professor Khoa Dinh Nguyen
Cho Ray Hospital, Ho Chi Minh City, VIETNAM
Professor Wen-Chan Tsai
Kaohsiung Medical University Hospital, Kaohsiung, TAIWAN
CH4: Morning symposium 7
Denosumab, anti-RANKL antibody, for the treatment of joint destruction in RA. − From DRIVE & DESIRABLE studies
Chairpersons:
Professor Tatsuya Atsumi
Professor of Medicine in the Faculty of Medicine / Hokkaido University
Speakers:
Professor Tsutomu Takeuchi
Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine
Brought to you by
Brought to you by
Brought to you by
1315 – 1445
CH1: Lunch symposium 3
New insights for clinical practice in Spondyloarthritis, SpA
Chairpersons:
Associate Professor Yuko Kaneko
Associate Professor, Division of Rheumatology and Department of Internal Medicine/Keio University School of Medicine
Professor Naoto Tamura
Professor and Chairman, Department of Internal Medicine and Rheumatology/Juntendo University School of Medicine
Speakers:
Dr Kei Ikeda
Senior Lecturer, Department of Allergy and Clinical Immunology/Chiba University Hospital
Dr Kenta Misaki
Chief Director, Department of Rheumatology/Kita-Harima Medical Center
Professor Yuho Kadono
Chief Administrator, Orthopedic Surgery/Saitama Medical University
CH2: Lunch symposium 4
Innovative therapeutic alternatives for RA, PsA, AS and nr-axSpA: Individualising the treatment approach
Chairperson:
Dr Kunihiro Yamaoka
Division of Rheumatology, Kitasato University Hospital, Japan
Speakers:
Dr Kunihiro Yamaoka
Division of Rheumatology, Kitasato University Hospital, Japan
Professor Lars Erik Kristensen
Parker Institute / University Copenhagen
Professor Andrew Ostör
Cabrini Medical Centre / Emeritus Research
Brought to you by
Brought to you by
1740 – 1840
CH1: Evening symposium 5
Addressing Unmet Needs in RA and PsA: The Right Drug for the Right Patient
Chairpersons:
Professor Tsutomu Takeuchi
Professor of Rheumatology,
Department of Internal Medicine/Keio University School of Medicine
Speakers:
Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine / School of Medicine,
University of Occupational and Environmental Health
Professor Filip Van den Bosch
Professor of Rheumatology and Head-of-Clinic,
Department of Rheumatology
/ University Hospital of Ghent University
Professor Tsutomu Takeuchi
Professor of Rheumatology,
Department of Internal Medicine/Keio University School of Medicine
CH2: Evening symposium 6
Evolution of interleukin-6 inhibiting therapies for rheumatoid arthritis
Chairpersons:
Dr Yutaka Kawahito M.D., Ph.D.
Head of the Department of Inflammation and Immunology/Kyoto Prefectural University of Medicine
Speakers:
Dr Motomu Hashimoto
Department of Advanced Medicine for Rheumatic Diseases, Kyoto University.
Brought to you by
Brought to you by
Wednesday 28 October 2020
1630-1730
Evening symposium 3
ILD in Focus: Time to prioritize the lung in CTDs
Chairperson:
Professor Masataka Kuwana
Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence / Nippon Medical School
Speakers:
Professor Marco Matucci-Cerinic
Professor of Rheumatology and Medicine at the Department of Experimental and Clinical Medicine/Careggi University Hospital of Florence
Professor Yannick Allanore
Professor of Rheumatology / University of Paris
Professor Masataka Kuwana
Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence / Nippon Medical School
Brought to you by
Translate »
Cookie Notice
This website uses cookies. By continuing to use this site, you accept our use of cookies. Please see our privacy policy for more information